Showing results (1301-1310 of 3,021) with videos related to

Sort By:
Pageof 303
Current Pharmaceutical Biotechnology|February 28, 2017
Clinical Applications of Personalized Medicine: A New Paradigm and ChallengeMariantonia Di Sanzo, Luigi Cipolloni, Marina Borro, et al.
Current Pharmaceutical Biotechnology|March 15, 2019
Corticosteroid Catabolism by Klebsiella pneumoniae as a Possible Mechanism for Increased Pneumonia RiskPritam Chattopadhyay, Goutam Banerjee
Current Pharmaceutical Biotechnology|April 6, 2019
Tanshinone IIA Promotes Macrophage Cholesterol Efflux and Attenuates Atherosclerosis of apoE-/- Mice by Omentin-1/ABCA1 PathwayYu-Lin Tan, Han-Xiao Ou, Min Zhang, et al.
Current Pharmaceutical Biotechnology|August 20, 2019
Ethnobotany and Pharmacology of Pinus Species Growing Naturally in Indian Himalayas: A Plant ReviewLav Singh, Pooja Dixit, Ravi P Srivastava, et al.
Current Pharmaceutical Biotechnology|August 5, 2019
Cry1A Proteins are Cytotoxic to HeLa but not to SiHa Cervical Cancer CellsGretel Mendoza-Almanza, Leticia Rocha-Zavaleta, Cecilia Aguilar-Zacarías, et al.
Current Pharmaceutical Biotechnology|August 5, 2019
Structure, Genome, Infection Cycle and Clinical Manifestations Associated with Human PapillomavirusSrishti Vashisht, Harshita Mishra, Pawan K Mishra, et al.
Current Pharmaceutical Biotechnology|November 7, 2018
Scorpion Toxins Targeting Voltage-gated Sodium Channels Associated with PainYijia Xu, Junxin Sun, Hongyu Liu, et al.
Current Pharmaceutical Biotechnology|November 13, 2018
Effect of Vinca Alkaloids on the Expression Levels of microRNAs Targeting Apoptosis-related Genes in Breast Cancer Cell LinesAdamantios V Mavrogiannis, Ioanna Kokkinopoulou, Christos K Kontos, et al.
Current Pharmaceutical Biotechnology|November 13, 2018
Evidence for L-Dopa Decarboxylase Involvement in Cancer Cell Cytotoxicity Induced by Docetaxel and MitoxantroneEvangelos D Kalantzis, Andreas Scorilas, Dido Vassilacopoulou
Pageof 303